Impact of Diabetes on 10‐Year Outcomes Following ST‐Segment–Elevation Myocardial Infarction: Insights From the EXAMINATION‐EXTEND Trial

Background Long‐term outcomes of ST‐segment–elevation myocardial infarction in patients with diabetes have been barely investigated. The objective of this analysis from the EXAMINATION‐EXTEND (10‐Years Follow‐Up of the EXAMINATION trial) trial was to compare 10‐year outcomes of patients with ST‐segm...

Full description

Bibliographic Details

Published in:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Main Authors:	Francesco Spione, Victor Arevalos, Rami Gabani, Luis Ortega‐Paz, Josep Gomez‐Lara, Victor Jimenez‐Diaz, Marcelo Jimenez, Pilar Jiménez‐Quevedo, Roberto Diletti, Javier Pineda, Gianluca Campo, Antonio Silvestro, Jaume Maristany, Xacobe Flores, Loreto Oyarzabal, Guillermo Bastos‐Fernandez, Andrés Iñiguez, Antonio Serra, Javier Escaned, Alfonso Ielasi, Maurizio Tespili, Mattie Lenzen, Nieves Gonzalo, Pascual Bordes, Matteo Tebaldi, Simone Biscaglia, Soheil Al‐Shaibani, Rafael Romaguera, Joan Antoni Gomez‐Hospital, Josep Rodes‐Cabau, Patrick W. Serruys, Manel Sabaté, Salvatore Brugaletta
Format:	Article
Language:	English
Published:	Wiley 2022-12-01
Subjects:	diabetes drug‐eluting stent percutaneous coronary intervention ST‐segment–elevation myocardial infarction
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.122.025885